{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:08:00Z","timestamp":1791256080629,"version":"4.1.0"},"reference-count":105,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Shenzhen Science and Technology Planning Project","award":["JCYJ20190812161605538"],"award-info":[{"award-number":["JCYJ20190812161605538"]}]},{"name":"Shenzhen Key Laboratory","award":["ZDSYS20210623092000002"],"award-info":[{"award-number":["ZDSYS20210623092000002"]}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"crossref","award":["2018A030313181"],"award-info":[{"award-number":["2018A030313181"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Traditional Chinese Medicine Hospital \u201c3030 Program\u201d Chinese Medicine Clinical Project","award":["G3030202115"],"award-info":[{"award-number":["G3030202115"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n               <jats:title>Background<\/jats:title>\n               <jats:p>Nonalcoholic fatty liver disease (NAFLD) is a metabolic disease, the incidence of which increases annually. Shugan Xiaozhi (SGXZ) decoction, a composite traditional Chinese medicinal prescription, has been demonstrated to exert a therapeutic effect on NAFLD. In this study, the potential bioactive ingredients and mechanism of SGXZ decoction against NAFLD were explored via network pharmacology, molecular docking, and molecular dynamics simulation.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Methods<\/jats:title>\n               <jats:p>Compounds in SGXZ decoction were identified and collected from the literature, and the corresponding targets were predicted through the Similarity Ensemble Approach database. Potential targets related to NAFLD were searched on DisGeNET and GeneCards databases. The compound\u2013target\u2013disease and protein-protein interaction (PPI) networks were constructed to recognize key compounds and targets. Functional enrichment analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) was performed on the targets. Molecular docking was used to further screen the potent active compounds in SGXZ. Finally, molecular dynamics (MD) simulation was applied to verify and validate the binding between the most potent compound and targets.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Results<\/jats:title>\n               <jats:p>A total of 31 active compounds and 220 corresponding targets in SGXZ decoction were collected. Moreover, 1,544 targets of NAFLD were obtained, of which 78 targets intersected with the targets of SGXZ decoction. Key compounds and targets were recognized through the compound\u2013target\u2013disease and PPI network. Multiple biological pathways were annotated, including PI3K-Akt, MAPK, insulin resistance, HIF-1, and tryptophan metabolism. Molecular docking showed that gallic acid, chlorogenic acid and isochlorogenic acid A could combine with the key targets. Molecular dynamics simulations suggested that isochlorogenic acid A might potentially bind directly with RELA, IL-6, VEGFA, and MMP9 in the regulation of PI3K\u2013Akt signaling pathway.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Conclusion<\/jats:title>\n               <jats:p>This study investigated the active substances and key targets of SGXZ decoction in the regulation of multiple-pathways based on network pharmacology and computational approaches, providing a theoretical basis for further pharmacological research into the potential mechanism of SGXZ in NAFLD.<\/jats:p>\n            <\/jats:sec>","DOI":"10.7717\/peerj.14171","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T09:17:22Z","timestamp":1668071842000},"page":"e14171","source":"Crossref","is-referenced-by-count":11,"title":["Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation"],"prefix":"10.7717","volume":"10","author":[{"given":"Rong","family":"Yang","sequence":"first","affiliation":[{"name":"Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dansheng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"10.7717\/peerj.14171\/ref-1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5681\/apb.2014.036","article-title":"Protective effects of N-acetylcysteine against the statins cytotoxicity in freshly isolated rat hepatocytes","volume":"4","author":"Abdoli","year":"2014","journal-title":"Advanced Pharmaceutical Bulletin"},{"key":"10.7717\/peerj.14171\/ref-2","doi-asserted-by":"publisher","first-page":"e10446","DOI":"10.7759\/cureus.10446","article-title":"Pleiotropic effects of statins in the light of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"12","author":"Ahsan","year":"2020","journal-title":"Cureus"},{"key":"10.7717\/peerj.14171\/ref-3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10787-018-0458-0","article-title":"IL-6 signalling pathways and the development of type 2 diabetes","volume":"26","author":"Akbari","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.7717\/peerj.14171\/ref-4","doi-asserted-by":"publisher","first-page":"14230","DOI":"10.1038\/s41598-018-32586-w","article-title":"HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver","volume":"8","author":"Arai","year":"2018","journal-title":"Scientific Reports"},{"key":"10.7717\/peerj.14171\/ref-5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"9","key":"10.7717\/peerj.14171\/ref-6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/md19090495","article-title":"Dieckol decreases caloric intake and attenuates nonalcoholic fatty liver disease and hepatic lymphatic vessel dysfunction in high-fat-diet-fed mice","volume":"19","author":"Byun","year":"2021","journal-title":"Marine Drugs"},{"key":"10.7717\/peerj.14171\/ref-7","doi-asserted-by":"publisher","first-page":"110513","DOI":"10.1016\/j.biopha.2020.110513","article-title":"Recent progress in the study of Artemisiae Scopariae Herba (Yin Chen), a promising medicinal herb for liver diseases","volume":"130","author":"Cai","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"10.7717\/peerj.14171\/ref-8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/molecules23020353","article-title":"VSpipe, an integrated resource for virtual screening and hit selection: applications to protein tyrosine phospahatase inhibition","volume":"23","author":"\u00c1lvarez-Carretero","year":"2018","journal-title":"Molecules"},{"key":"10.7717\/peerj.14171\/ref-9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jhep.2012.11.031","article-title":"Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease","volume":"58","author":"Centis","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.7717\/peerj.14171\/ref-10","doi-asserted-by":"publisher","first-page":"e10124","DOI":"10.15252\/emmm.201810124","article-title":"Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis","volume":"11","author":"Challa","year":"2019","journal-title":"EMBO Molecular Medicine"},{"key":"10.7717\/peerj.14171\/ref-11","doi-asserted-by":"publisher","first-page":"606759","DOI":"10.3389\/fphar.2020.606759","article-title":"Gallic acid ameliorated impaired lipid homeostasis in a mouse model of high-fat diet-and streptozotocin-induced NAFLD and diabetes through improvement of \u03b2-oxidation and ketogenesis","volume":"11","author":"Chao","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.14171\/ref-12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/bmb\/ldaa006","article-title":"Obeticholic acid-a new therapy in PBC and NASH","volume":"133","author":"Chapman","year":"2020","journal-title":"British Medical Bulletin"},{"key":"10.7717\/peerj.14171\/ref-13","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1111\/jcmm.14079","article-title":"MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K\/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus","volume":"23","author":"Chen","year":"2019","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"20","key":"10.7717\/peerj.14171\/ref-14","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.3390\/ijms20205055","article-title":"Exploration and development of PPAR modulators in health and disease: an update of clinical evidence","volume":"20","author":"Cheng","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.7717\/peerj.14171\/ref-15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the american association for the Study of Liver Diseases (AASLD)","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocrine Practice"},{"key":"10.7717\/peerj.14171\/ref-16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13020-021-00469-4","article-title":"Traditional Chinese medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"16","author":"Dai","year":"2021","journal-title":"Chinese Medical Journal"},{"key":"10.7717\/peerj.14171\/ref-17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.acthis.2009.05.005","article-title":"Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection","volume":"112","author":"D\u2019Amico","year":"2010","journal-title":"Acta Histochemica"},{"key":"10.7717\/peerj.14171\/ref-18","doi-asserted-by":"publisher","first-page":"100714","DOI":"10.1016\/j.jbc.2021.100714","article-title":"NF-\u03baB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet","volume":"296","author":"Daniel","year":"2021","journal-title":"Journal of Biological Chemistry"},{"key":"10.7717\/peerj.14171\/ref-19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.phrs.2019.01.029","article-title":"Interactions between gut microbiota and non-alcoholic liver disease: the role of microbiota-derived metabolites","volume":"141","author":"Ding","year":"2019","journal-title":"Pharmacological Research"},{"key":"10.7717\/peerj.14171\/ref-20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.22038\/ajp.2021.17835","article-title":"Gallic acid protects the liver against NAFLD induced by dust exposure and high-fat diet through inhibiting oxidative stress and repressing the inflammatory signaling pathways NF-k \u03b2\/TNF-\u03b1\/IL-6 in Wistar rats","volume":"11","author":"Fanaei","year":"2021","journal-title":"Avicenna Journal of Phytomedicine"},{"key":"10.7717\/peerj.14171\/ref-21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.22038\/ijbms.2021.51036.11603","article-title":"Gallic acid treats dust-induced NAFLD in rats by improving the liver\u2019s anti-oxidant capacity and inhibiting ROS\/NF \u03ba\u03b2\/TNF \u03b1 inflammatory pathway","volume":"24","author":"Fanaei","year":"2021","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"10.7717\/peerj.14171\/ref-22","doi-asserted-by":"publisher","first-page":"771459","DOI":"10.3389\/fphar.2021.771459","article-title":"The potential application of Chinese medicine in liver diseases: a new opportunity","volume":"12","author":"Fu","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.14171\/ref-23","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.2174\/138161212803530763","article-title":"NF-\u03baB as a target for modulating inflammatory responses","volume":"18","author":"Gasparini","year":"2012","journal-title":"Current Pharmaceutical Design"},{"key":"10.7717\/peerj.14171\/ref-24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41575-021-00473-x","article-title":"New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology","volume":"18","author":"Giraldez","year":"2021","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.7717\/peerj.14171\/ref-25","doi-asserted-by":"publisher","first-page":"e0260313","DOI":"10.1371\/journal.pone.0260313","article-title":"Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: a pilot study","volume":"16","author":"Goyale","year":"2021","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.14171\/ref-26","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3389\/fphar.2019.01185","article-title":"Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula zuojin pill in suppressing hepatocellular carcinoma","volume":"10","author":"Guo","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.14171\/ref-27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jep.2012.09.003","article-title":"Hepatoprotective and antiviral properties of isochlorogenic acid A from Laggera alata against hepatitis B virus infection","volume":"144","author":"Hao","year":"2012","journal-title":"Journal of Ethnopharmacology"},{"key":"10.7717\/peerj.14171\/ref-28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.gastrohep.2020.09.014","article-title":"Silencing HIF-1\u03b1 aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-\u03b1\/ANGPTL4 singling pathway","volume":"44","author":"He","year":"2021","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.7717\/peerj.14171\/ref-29","doi-asserted-by":"publisher","first-page":"753268","DOI":"10.3389\/fmed.2021.753268","article-title":"Hypoxia-inducible factors as key players in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"8","author":"Holzner","year":"2021","journal-title":"Frontiers in Medicine"},{"key":"10.7717\/peerj.14171\/ref-30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang Da","year":"2009","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.14171\/ref-31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang Da","year":"2009","journal-title":"Nature Protocols"},{"key":"10.7717\/peerj.14171\/ref-32","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.7717\/peerj.14171\/ref-33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/medicina55050166","article-title":"Dietary and pharmacological treatment of nonalcoholic fatty liver disease","volume":"55","author":"Jeznach-Steinhagen","year":"2019","journal-title":"Medicina"},{"key":"10.7717\/peerj.14171\/ref-34","doi-asserted-by":"publisher","first-page":"107402","DOI":"10.1016\/j.compbiolchem.2020.107402","article-title":"A comprehensive application: Molecular docking and network pharmacology for the prediction of bioactive constituents and elucidation of mechanisms of action in component-based Chinese medicine","volume":"90","author":"Jiao","year":"2021","journal-title":"Computational Biology and Chemistry"},{"key":"10.7717\/peerj.14171\/ref-35","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1136\/gut.2008.151977","article-title":"High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Gut"},{"key":"10.7717\/peerj.14171\/ref-36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nature Biotechnology"},{"key":"10.7717\/peerj.14171\/ref-37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"10.7717\/peerj.14171\/ref-38","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)","volume":"306","author":"Klein","year":"2011","journal-title":"JAMA"},{"key":"10.7717\/peerj.14171\/ref-39","doi-asserted-by":"publisher","first-page":"16364","DOI":"10.1038\/s41598-020-73347-y","article-title":"Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance","volume":"10","author":"Kochumon","year":"2020","journal-title":"Scientific Reports"},{"key":"10.7717\/peerj.14171\/ref-40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2017.10.015","article-title":"Pharmacotherapy for NASH: current and emerging","volume":"68","author":"Konerman","year":"2018","journal-title":"Journal of Hepatology"},{"key":"10.7717\/peerj.14171\/ref-41","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1002\/hep.32094","article-title":"Letter to the Editor: saroglitazar for treatment of NAFLD and NASH","volume":"74","author":"Kumar","year":"2021","journal-title":"Hepatology"},{"key":"10.7717\/peerj.14171\/ref-42","doi-asserted-by":"publisher","first-page":"7299","DOI":"10.1038\/s41598-019-43759-6","article-title":"Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis","volume":"9","author":"Lachowski","year":"2019","journal-title":"Scientific Reports"},{"key":"10.7717\/peerj.14171\/ref-43","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3389\/fphar.2020.01194","article-title":"Editorial: network pharmacology and traditional medicine","volume":"11","author":"Lai","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.14171\/ref-44","first-page":"301","article-title":"Angiogenesis in the progression of non-alcoholic fatty liver disease","volume":"83","author":"Lefere","year":"2020","journal-title":"Acta Gastro-Enterologica Belgica"},{"key":"10.7717\/peerj.14171\/ref-45","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3390\/jcm10071338","article-title":"Role of Angiogenesis in the Pathogenesis of NAFLD","volume":"10","author":"Lei","year":"2021","journal-title":"Journal of Clinical Medicine"},{"key":"10.7717\/peerj.14171\/ref-46","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.2147\/dmso.S274534","article-title":"The mechanism of traditional Chinese medicine for the treatment of obesity","volume":"13","author":"Li","year":"2020","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"key":"10.7717\/peerj.14171\/ref-47","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ijbiomac.2019.09.118","article-title":"Roles of galectin-3 in metabolic disorders and tumor cell metabolism","volume":"142","author":"Li","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.7717\/peerj.14171\/ref-48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/hnp.0000000000000311","article-title":"Traditional Chinese medicine and intestinal microbiota: a complementary and integrative health approach to ameliorate obesity-related diseases","volume":"33","author":"Liang","year":"2019","journal-title":"Holistic Nursing Practice"},{"key":"10.7717\/peerj.14171\/ref-49","doi-asserted-by":"publisher","first-page":"e013927","DOI":"10.1136\/bmjopen-2016-013927","article-title":"Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis","volume":"7","author":"Liao","year":"2017","journal-title":"BMJ Open"},{"key":"10.7717\/peerj.14171\/ref-50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.mce.2017.10.010","article-title":"LAMP3 regulates hepatic lipid metabolism through activating PI3K\/Akt pathway","volume":"470","author":"Liao","year":"2018","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.7717\/peerj.14171\/ref-51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome","volume":"7","author":"Lim","year":"2010","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.7717\/peerj.14171\/ref-52","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA"},{"key":"10.7717\/peerj.14171\/ref-53","doi-asserted-by":"publisher","first-page":"9301","DOI":"10.1007\/s11033-020-05990-7","article-title":"Regulation of chlorogenic acid, flavonoid, and iridoid biosynthesis by histone H3K4 and H3K9 methylation in Lonicera japonica","volume":"47","author":"Liu","year":"2020","journal-title":"Molecular Biology Reports"},{"key":"10.7717\/peerj.14171\/ref-54","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fphar.2020.00582","article-title":"Isochlorogenic acid A attenuates the progression of liver fibrosis through regulating HMGB1\/TLR4\/NF-\u03baB signaling pathway","volume":"11","author":"Liu","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.14171\/ref-55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/17460441.2018.1403419","article-title":"Molecular dynamics simulations and novel drug discovery","volume":"13","author":"Liu","year":"2018","journal-title":"Expert Opinion on Drug Discovery"},{"key":"10.7717\/peerj.14171\/ref-56","first-page":"696","article-title":"Network pharmacology: new opportunity for the modernization of traditional Chinese medicine","volume":"47","author":"Liu","year":"2012","journal-title":"Yao Xue Xue Bao"},{"key":"10.7717\/peerj.14171\/ref-57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"Journal of Hepatology"},{"issue":"10","key":"10.7717\/peerj.14171\/ref-58","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/nu9101124","article-title":"Gut microbiota and nonalcoholic fatty liver disease: insights on mechanisms and therapy","volume":"9","author":"Ma","year":"2017","journal-title":"Nutrients"},{"key":"10.7717\/peerj.14171\/ref-59","doi-asserted-by":"publisher","first-page":"e7929","DOI":"10.1371\/journal.pone.0007929","article-title":"IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis","volume":"4","author":"Mas","year":"2009","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.14171\/ref-60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1586\/epr.09.59","article-title":"Proteomics and liver fibrosis: identifying markers of fibrogenesis","volume":"6","author":"Mas","year":"2009","journal-title":"Expert Review of Proteomics"},{"key":"10.7717\/peerj.14171\/ref-61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller 3rd","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.7717\/peerj.14171\/ref-62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ncp.10449","article-title":"Evolution of NAFLD and its management","volume":"35","author":"Mundi","year":"2020","journal-title":"Nutrition in Clinical Practice"},{"key":"10.7717\/peerj.14171\/ref-63","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/his.13665","article-title":"Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease","volume":"73","author":"Munsterman","year":"2018","journal-title":"Histopathology"},{"key":"10.7717\/peerj.14171\/ref-64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fendo.2015.00193","article-title":"Fibroblast growth factor signaling in metabolic regulation","volume":"6","author":"Nies","year":"2015","journal-title":"Frontiers in Endocrinology"},{"key":"10.7717\/peerj.14171\/ref-65","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.7717\/peerj.14171\/ref-66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.fct.2015.05.016","article-title":"Atorvastatin induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase12 dependent pathways","volume":"83","author":"Pal","year":"2015","journal-title":"Food and Chemical Toxicology"},{"key":"10.7717\/peerj.14171\/ref-67","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkz1021","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.14171\/ref-68","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1074\/jbc.REV118.002804","article-title":"The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: Getting by with a little help from ERdj friends","volume":"294","author":"Pobre","year":"2019","journal-title":"Journal of Biological Chemistry"},{"key":"10.7717\/peerj.14171\/ref-69","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Frontiers in Bioscience-Landmark"},{"key":"10.7717\/peerj.14171\/ref-70","doi-asserted-by":"publisher","first-page":"112357","DOI":"10.1016\/j.biopha.2021.112357","article-title":"Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids","volume":"144","author":"Sarkar","year":"2021","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.7717\/peerj.14171\/ref-71","doi-asserted-by":"publisher","first-page":"693048","DOI":"10.3389\/fphar.2021.693048","article-title":"Chlorogenic acid improves NAFLD by regulating gut microbiota and GLP-1","volume":"12","author":"Shi","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.14171\/ref-72","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.2147\/dddt.S341223","article-title":"Saroglitazar\u2014a potential therapeutic option in treating NASH?","volume":"15","author":"Shuja","year":"2021","journal-title":"Drug Design, Development and Therapy"},{"key":"10.7717\/peerj.14171\/ref-73","doi-asserted-by":"publisher","first-page":"158905","DOI":"10.1016\/j.bbalip.2021.158905","article-title":"Chronic systemic exposure to IL6 leads to deregulation of glycolysis and fat accumulation in the zebrafish liver","volume":"1866","author":"Singh","year":"2021","journal-title":"Biochimica et Biophysica Acta\u2014Molecular and Cell Biology of Lipids"},{"key":"10.7717\/peerj.14171\/ref-74","doi-asserted-by":"publisher","first-page":"655659","DOI":"10.3389\/fphar.2021.655659","article-title":"Discovery and characterization of the biflavones from ginkgo biloba as highly specific and potent inhibitors against human carboxylesterase 2","volume":"12","author":"Song","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.14171\/ref-75","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/s2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"10.7717\/peerj.14171\/ref-76","doi-asserted-by":"publisher","first-page":"1.30.31","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Current Protocols in Bioinformatics"},{"key":"10.7717\/peerj.14171\/ref-77","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3906\/sag-1404-136","article-title":"Effect of pioglitazone, quercetin, and hydroxy citric acid on vascular endothelial growth factor messenger RNA (VEGF mRNA) expression in experimentally induced nonalcoholic steatohepatitis (NASH)","volume":"45","author":"Surapaneni","year":"2015","journal-title":"The Turkish Journal of Medical Sciences"},{"key":"10.7717\/peerj.14171\/ref-78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.7717\/peerj.14171\/ref-79","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.14171\/ref-80","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.3748\/wjg.v21.i13.3777","article-title":"Current pharmacological therapies for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"21","author":"Takahashi","year":"2015","journal-title":"World Journal of Gastroenterology"},{"key":"10.7717\/peerj.14171\/ref-81","doi-asserted-by":"publisher","first-page":"594","DOI":"10.13288\/j.11-2166\/r.2018.07.014","article-title":"Evaluating the clinical effect of modified shugan xiaozhi decoction in treating nonalcoholic fatty liver disease based on fibroscan technique","volume":"59","author":"Tang","year":"2018","journal-title":"Journal of Traditional Chinese Medicine"},{"key":"10.7717\/peerj.14171\/ref-82","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: when pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.7717\/peerj.14171\/ref-83","doi-asserted-by":"publisher","first-page":"8327945","DOI":"10.1155\/2020\/8327945","article-title":"Expression of matrix metalloproteinases and their tissue inhibitors in peripheral blood leukocytes and plasma of children with nonalcoholic fatty liver disease","volume":"2020","author":"Trojanek","year":"2020","journal-title":"Mediators of Inflammation"},{"key":"10.7717\/peerj.14171\/ref-84","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/oby.20662","article-title":"Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study","volume":"22","author":"Wadden","year":"2014","journal-title":"Obesity"},{"key":"10.7717\/peerj.14171\/ref-85","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.3390\/molecules24183390","article-title":"Trilobatin, a novel SGLT1\/2 inhibitor, selectively induces the proliferation of human hepatoblastoma cells","volume":"24","author":"Wang","year":"2019","journal-title":"Molecules"},{"key":"10.7717\/peerj.14171\/ref-86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1875-5364(21)60001-8","article-title":"TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches","volume":"19","author":"Wang","year":"2021","journal-title":"Chinese Journal of Natural Medicines"},{"key":"10.7717\/peerj.14171\/ref-87","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.14171\/ref-88","doi-asserted-by":"publisher","first-page":"5599997","DOI":"10.1155\/2021\/5599997","article-title":"Epigallocatechin-3-gallate alleviates high-fat diet-induced nonalcoholic fatty liver disease via inhibition of apoptosis and promotion of autophagy through the ROS\/MAPK signaling pathway","volume":"2021","author":"Wu","year":"2021","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.7717\/peerj.14171\/ref-89","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/abbs\/gmy169","article-title":"Chronic intermittent hypoxia accelerates liver fibrosis in rats with combined hypoxia and nonalcoholic steatohepatitis via angiogenesis rather than endoplasmic reticulum stress","volume":"51","author":"Wu","year":"2019","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"10.7717\/peerj.14171\/ref-90","doi-asserted-by":"publisher","first-page":"7870189","DOI":"10.1155\/2016\/7870189","article-title":"Shugan Xiaozhi decoction attenuates nonalcoholic steatohepatitis by enhancing PPAR \u03b1 and L-FABP expressions in high-fat-fed rats","volume":"2016","author":"Xing","year":"2016","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"10.7717\/peerj.14171\/ref-91","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2147\/dmso.S206867","article-title":"Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2\/PI3K\/Akt signaling pathway","volume":"12","author":"Yang","year":"2019","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"key":"10.7717\/peerj.14171\/ref-92","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1080\/13880209.2021.1945112","article-title":"Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1\/NF-\u03baB p65 pathway","volume":"59","author":"Yang","year":"2021","journal-title":"Pharmaceutical Biology"},{"key":"10.7717\/peerj.14171\/ref-93","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s42003-021-02735-5","article-title":"Activation of the adipocyte CREB\/CRTC pathway in obesity","volume":"4","author":"Yoon","year":"2021","journal-title":"Communications Biology"},{"key":"10.7717\/peerj.14171\/ref-94","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.7717\/peerj.14171\/ref-95","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.7717\/peerj.14171\/ref-96","doi-asserted-by":"publisher","first-page":"110043","DOI":"10.1016\/j.cellsig.2021.110043","article-title":"Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPAR \u03b3\/CD36 signaling pathway","volume":"84","author":"Yu","year":"2021","journal-title":"Cell Signal"},{"key":"10.7717\/peerj.14171\/ref-97","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/iub.2424","article-title":"Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice","volume":"73","author":"Zamani-Garmsiri","year":"2021","journal-title":"IUBMB Life"},{"key":"10.7717\/peerj.14171\/ref-98","first-page":"78","article-title":"Clinical efficacy of Shugan Xiaozhi granules in treatment of nonalcoholic steatohepatitis","volume":"24","author":"Zhai","year":"2014","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases"},{"key":"10.7717\/peerj.14171\/ref-99","first-page":"721","article-title":"Study on the enterogenic mechanism of Shugan Xiaozhi decoction in treating NAFLD by regulating apoB48","volume":"31","author":"Zhai","year":"2021","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases"},{"key":"10.7717\/peerj.14171\/ref-100","doi-asserted-by":"publisher","first-page":"110857","DOI":"10.1016\/j.biopha.2020.110857","article-title":"Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota","volume":"133","author":"Zhang","year":"2021","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.7717\/peerj.14171\/ref-101","doi-asserted-by":"publisher","first-page":"107248","DOI":"10.1016\/j.compbiolchem.2020.107248","article-title":"Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease","volume":"86","author":"Zhang","year":"2020","journal-title":"Computational Biology and Chemistry"},{"key":"10.7717\/peerj.14171\/ref-102","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2019.00123","article-title":"Network pharmacology databases for traditional Chinese medicine: review and assessment","volume":"10","author":"Zhang","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.14171\/ref-103","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"10.7717\/peerj.14171\/ref-104","doi-asserted-by":"publisher","first-page":"1646905","DOI":"10.1155\/2020\/1646905","article-title":"Applications of network pharmacology in traditional Chinese medicine research","volume":"2020","author":"Zhou","year":"2020","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"555","key":"10.7717\/peerj.14171\/ref-105","doi-asserted-by":"publisher","first-page":"eaax8096","DOI":"10.1126\/scitranslmed.aax8096","article-title":"Estrogen receptor \u03b1 controls metabolism in white and brown adipocytes by regulating Polg1 and mitochondrial remodeling","volume":"12","author":"Zhou","year":"2020","journal-title":"Science Translational Medicine"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/14171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/14171.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/14171.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/14171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T09:17:46Z","timestamp":1668071866000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/14171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":105,"alternative-id":["10.7717\/peerj.14171"],"URL":"https:\/\/doi.org\/10.7717\/peerj.14171","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"article-number":"e14171"}}